Standing next to Pfizer CEO Albert Borla in the Oval Office last week, President Donald Trump announced that the pharma giant had made a startling concession: It would voluntarily lower the prices it charges Americans for its medicines. At the same time, the White House announced plans for TrumpRx, a new government website, that would launch next year, where US patients could purchase prescription drugs directly from drugmakers.
Read Full Article ⟶